Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shawn M. Egan"'
Autor:
Shawn M. Egan, Scott H. Olejniczak, Qing Xiang, Megan R. Radler, Gaspare La Rocca, Craig B. Thompson, Ralph Garippa
Publikováno v:
Molecular and Cellular Biology. 36:2360-2373
Cell growth and proliferation require the coordinated activation of many cellular processes, including cap-dependent mRNA translation. MicroRNAs oppose cap-dependent translation and set thresholds for expression of target proteins. Emerging data sugg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae806f62809d7cc94ed3c9c94ff6f0c1
https://doi.org/10.1128/mcb.01011-15
https://doi.org/10.1128/mcb.01011-15
Autor:
G. Aaron Holling, Rachel L. Kandefer, Scott H. Olejniczak, Michael J. Nemeth, Seerat Elahi, Shawn M. Egan
Publikováno v:
Experimental Hematology. 64:45-58.e9
Recent biochemical characterization of Arsenic resistance protein 2 (Ars2) has established it as central to determining the fate of nascent RNA polymerase II (RNAPII) transcripts. Through interactions with the nuclear 5′-7-methylguanosine (7mG) cap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77bdca84e7de031a0f8a34ce913772cf
https://doi.org/10.1016/j.exphem.2018.05.001
https://doi.org/10.1016/j.exphem.2018.05.001
Publikováno v:
Oncotarget
// Shawn M. Egan 1 , Ellen Karasik 2 , Leigh Ellis 3 and Sandra O. Gollnick 4 1 Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263, USA 2 Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba130ee24766db74e3b1b4cef5eab65
https://pubmed.ncbi.nlm.nih.gov/28978058
https://pubmed.ncbi.nlm.nih.gov/28978058
Autor:
Shawn M Egan, Sandra O Gollnick
Publikováno v:
The Journal of Immunology. 196:213.17-213.17
Prostate cancer (CaP) is a critical problem for the aging male population. CaP is managed using a combination of prostatectomy, androgen ablation, chemotherapy and radiation. Subsets of patients develop androgen-insensitive metastatic CaP for which t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a02e4c7bd2bd459b5782cfd77a9586f9
https://doi.org/10.4049/jimmunol.196.supp.213.17
https://doi.org/10.4049/jimmunol.196.supp.213.17